Streamline Health Valuation
| STRM Stock | USD 3.20 0.04 1.23% |
At this time, the company appears to be undervalued. Streamline Health has a current Real Value of $7.92 per share. The regular price of the company is $3.2. Our model measures the value of Streamline Health from inspecting the company fundamentals such as Return On Equity of -0.8, shares outstanding of 4.27 M, and Operating Margin of (0.71) % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Streamline Health's valuation include:
Price Book 0.9828 | Enterprise Value | Enterprise Value Ebitda (24.03) | Price Sales 0.7449 | Enterprise Value Revenue 1.3548 |
Undervalued
Today
Please note that Streamline Health's price fluctuation is slightly risky at this time. Calculation of the real value of Streamline Health is based on 3 months time horizon. Increasing Streamline Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Streamline stock is determined by what a typical buyer is willing to pay for full or partial control of Streamline Health Solutions. Since Streamline Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Streamline Stock. However, Streamline Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.2 | Real 7.92 | Target 22.5 | Hype 3.2 | Naive 3.31 |
The intrinsic value of Streamline Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Streamline Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Streamline Health Solutions helps investors to forecast how Streamline stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Streamline Health more accurately as focusing exclusively on Streamline Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Streamline Health's intrinsic value based on its ongoing forecasts of Streamline Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Streamline Health's closest peers.
Streamline Health Cash |
|
Streamline Valuation Trend
Knowing Streamline Health's actual value is paramount for traders when making sound investment determinations. Using both Streamline Health's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Streamline Revenue by Product
Streamline Health Total Value Analysis
Streamline Health Solutions is at this time projected to have valuation of 25.18 M with market capitalization of 15.34 M, debt of 10.57 M, and cash on hands of 5.92 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Streamline Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
25.18 M | 15.34 M | 10.57 M | 5.92 M |
Streamline Health Investor Information
About 24.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.98. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Streamline Health has Price/Earnings (P/E) ratio of 321.67. The entity recorded a loss per share of 2.35. The firm last dividend was issued on the 30th of September 2010. Streamline Health had 1:15 split on the 4th of October 2024. Streamline Health Solutions is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Streamline Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Streamline Health has an asset utilization ratio of 54.14 percent. This suggests that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that Streamline Health Solutions is more efficient with each dollar of assets it utilizes for everyday operations.Streamline Health Ownership Allocation
The market capitalization of Streamline Health is $15.34 Million. Streamline Health maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Streamline Health Profitability Analysis
The company reported the previous year's revenue of 22.6 M. Net Loss for the year was (18.7 M) with profit before overhead, payroll, taxes, and interest of 11.49 M.About Streamline Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Streamline Health Solutions. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Streamline Health based exclusively on its fundamental and basic technical indicators. By analyzing Streamline Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Streamline Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Streamline Health. We calculate exposure to Streamline Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Streamline Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 13.3 M | 9.9 M | |
| Pretax Profit Margin | (0.95) | (0.91) | |
| Operating Profit Margin | (1.00) | (0.95) | |
| Net Loss | (0.95) | (0.90) | |
| Gross Profit Margin | 0.46 | 0.40 |
Streamline Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Streamline Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.8 M | |
| Quarterly Earnings Growth Y O Y | 12.131 |
Streamline Health Current Valuation Indicators
Streamline Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Streamline Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Streamline Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Streamline Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Streamline Health's worth.When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (2.35) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.